OCUL · Ocular Therapeutix, Inc · Documents
Market Cap
$2.52B
Shares
219.62M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-03 | 2026-06-30 | |
| 8-K | 2026-08-03 | — | |
| 8-K | 2026-06-12 | 2026-06-10 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-30 | 2026-06-11 | |
| 8-K | 2026-02-27 | — | |
| 10-K | 2026-02-05 | 2025-12-31 | |
| 8-K | 2026-02-05 | — | |
| 8-K | 2026-01-23 | 2026-01-20 | |
| 8-K | 2025-12-18 | — | |
| 8-K | 2025-12-05 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-09-30 | — | |
| 8-K | 2025-09-30 | — | |
| 8-K | 2025-08-05 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-06-11 | — | |
| 8-K | 2025-05-05 | — | |
| 10-Q | 2025-05-05 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-11 | |
| 8-K | 2025-03-03 | — | |
| 10-K | 2025-03-03 | 2024-12-31 | |
| 8-K | 2025-02-14 | 2025-02-11 | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-10-09 | 2024-10-04 | |
| 8-K | 2024-09-03 | 2024-08-29 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-06-14 | 2024-06-12 | |
| 8-K | 2024-06-03 | 2024-05-29 | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-29 | 2024-06-12 | |
| 8-K | 2024-04-18 | 2024-04-14 | |
| 8-K | 2024-03-29 | 2024-03-28 | |
| 8-K | 2024-03-11 | — | |
| 10-K | 2024-03-11 | 2023-12-31 | |
| 8-K | 2024-02-22 | 2024-02-20 | |
| 8-K | 2024-01-25 | — | |
| 8-K | 2023-12-14 | 2023-12-13 | |
| 8-K | 2023-11-07 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-10-04 | — | |
| 8-K | 2023-10-03 | — | |
| 8-K | 2023-09-13 | 2023-09-12 | |
| 8-K | 2023-08-07 | — | |
| 10-Q | 2023-08-07 | 2023-06-30 |
Showing 1–50 of 118 filings
Key facts
CIK
1393434
CUSIP
67576A100
13F (30d)
153 filings
150 filers
Visit website
Investor relations